ROMANCE: Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section

Sponsor
University Hospital, Grenoble (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02410317
Collaborator
(none)
101
1
2
82.9
1.2

Study Details

Study Description

Brief Summary

The cesarean section is one of the most commonly performed surgeries in the world and it represents 20% of the births in France. Postoperative pain is moderate-to-severe during the first 48 hours after this procedure. Thereby its control is prominent for the medical team in order to shorten the duration of hospital stay as well as to permit an early return to daily activities for these surgical patients.

Pain control after cesarean section is usually based on non-opioids and epidural administration of morphine if an epidural catheter has been previously placed for the procedure. However epidural morphine is associated with a number of side effects. Wound infiltration with local anesthetics has been widely used in the multimodal management of postoperative pain and it may reduce postoperative morphine consumption.

In patients enrolled for emergency cesarean delivery with epidural catheter, the objective of this study will be to compare the analgesia provided by a local anesthetic wound 48-hours infusion through a multiorifice catheter (ropivacaine 2 mg/mL) versus epidural analgesia (epidural morphine bolus). Quality of pain control will be assessed with the measurements of morphine consumption and pain scores at rest and during mobilisation over 48 hours. At 3 months, patients will be interviewed to assess their residual pain and their satisfaction.

It is hypothesized that local anesthetic wound infusion would be non-inferior than epidural morphine analgesia to control pain after cesarean section, and be associated with a reduction of side effects related to the analgesics.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
101 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section
Actual Study Start Date :
Feb 1, 2015
Actual Primary Completion Date :
Aug 28, 2021
Anticipated Study Completion Date :
Dec 28, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Continuous wound infusion group

Patients receive analgesia through a multiorifice wound catheter connected to ropivacaine infusion. Saline solution is given in the epidural bolus.

Drug: Ropivacaine

Active Comparator: Epidural morphine group

Patients receive epidural analgesia through an epidural bolus of morphine. Saline solution is perfused through the wound catheter.

Drug: Morphine

Outcome Measures

Primary Outcome Measures

  1. Pain score during mobilization [at 24 hours]

    Visual analog scale for pain while the patient moves from lying to sitting

Secondary Outcome Measures

  1. Pain score at rest [at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)]

    Visual analog scale for pain while the patient is at rest

  2. Pain score during mobilization [at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)]

    Visual analog scale for pain while the patient moves from lying to sitting

  3. The incidence of morphine side effects: nausea, vomiting, pruritus [at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)]

    At every time points, side effects will be recorded

  4. Duration of Indwelling Urethral Catheters [at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)]

    At ever time points, the presence of urethral catheter will be recorded and total duration will be compared.

  5. Recovery of bowel function [at 2, 6(+/-1h), 12(+/-1h), 24(+/-2h), and 48 hours (+/-3h)]

    At ever time points, patients will be asked whether they recovered bowel function and total duration to recover bowel function will be compared.

  6. Morphine consumption dose [During hospital stay (an average of 3 days)]

    Total dose of morphine consumed for pain management after the epidural bolus

  7. Parturient satisfaction score [at 48 hours]

    Satisfaction about pain management and breastfeeding

  8. Complications during wound-catheter removal [at 48 hours]

    Fever, pain, difficulties and infection at removal

  9. Delay between birth and breastfeeding [During hospital stay (an average of 3 days)]

  10. Duration of stay [Hospital stay (an average of 3 days)]

  11. Residual pain [3 months]

    Numeric Rating Scale for Pain by phone interview

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Minimum age 18 years

  • ASA-1 and 2 Parturient

  • Emergency Cesarean delivery under epidural anesthesia

  • Suprapubic incision used for cesarean section

  • Functional epidural Catheter before the cesarean decision

(ASA Scores : Physical Status score)

Exclusion Criteria:
  • ASA-3 and 4 Parturient

  • BMI > 35 (before pregnancy)

  • Existing chronic pain

  • Contra-indication to study treatments

  • Chronic use of analgesics or morphinic

  • Preeclampsia

  • Infection

  • < 37 weeks pregnant +/- 3 days

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Couple Enfant - CHU de Grenoble Grenoble France

Sponsors and Collaborators

  • University Hospital, Grenoble

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Grenoble
ClinicalTrials.gov Identifier:
NCT02410317
Other Study ID Numbers:
  • Eudract 2014-002044-41
First Posted:
Apr 7, 2015
Last Update Posted:
Sep 29, 2021
Last Verified:
Sep 1, 2021

Study Results

No Results Posted as of Sep 29, 2021